ArticleEnvironmental monitoring and assessment2024
Removal of fluorouracil from aqueous environment using magnetite graphene oxide modified with γ-cyclodextrin.
Article in Environmental monitoring and assessment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
- Different Drug Mobilities in Hydrophobic Cavities of Host-Guest Complexes between β-Cyclodextrin and 5-Fluorouracil at Different Stoichiometries: A Molecular Dynamics Study in Water.International journal of molecular sciences · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorouracil (FU) is a widely utilized antineoplastic medication in the pharmaceutical industry for combating gastrointestinal cancers. However, its presence in wastewater originating from pharmaceutical facilities and hospital effluents has a potential effect on DNA, and cannot be efficiently eliminated through conventional treatment methods. Consequently, the adoption of advanced technologies becomes crucial for effectively treating such wastewater. Accordingly, this study investigated the efficiency of magnetite graphene oxide nanocomposite functionalized with γ-cyclodextrin for removing fluorouracil from aqueous solutions. The magnetite graphene oxide nanocomposite functionalized with γ-cyclodextrin was synthesized via the hydrothermal method. Next, the effect of pH, temperature, adsorbent content, and contact time on the fluorouracil removal efficiency was explored. Ultimately, the experimental data were matched against Langmuir, Freundlich, and Temkin isotherms and Kinetic models. Accordingly, the efficiency of the absorbent used was dependent on the pH, contact time, temperature, and initial concentration of the adsorbent. The results indicated that the maximum removal efficiency for fluorouracil was achieved within the contact time of 45 min and adsorbent content of 0.020 g. In addition, the optimal pH for removing the medicine was 7. The conditions of the adsorption process followed Langmuir isotherm with correlation coefficients of 0.992 and a quasi-second kinetic model with a correlation coefficient of 0.999, with the maximum adsorption capacity of the adsorbent synthesized for the evaluated medicine estimated as 190.9 mg/g. The results showed that the magnetite graphene oxide nanocomposite functionalized with γ-cyclodextrin could be used as an effective and available adsorbent for removing fluorouracil from pharmaceutical wastewater.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.